The Medicines Company CEO Clive Meanwell, An Interview With "The Pink Sheet" DAILY, (Part 1 Of 3)

While fighting for a patent extension for its sales leader, the specialty pharma has adjusted its business model to include acquisitions and early-stage drug development.